Targeting CCK Receptors in Human Cancers

Author(s): Jean Claude Reubi

Journal Name: Current Topics in Medicinal Chemistry

Volume 7 , Issue 12 , 2007

Become EABM
Become Reviewer
Call for Editor


Gut hormone receptors can be over-expressed in several human cancers and represent the basis for receptortargeted tumor imaging and therapy. A promising receptor for such clinical applications is the cholecystokinin receptor. Cholecystokinin receptors are expressed in numerous neuroendocrine tumors, in particular medullary thyroid carcinomas and neuroendocrine gut tumors, as well as in stromal tumors. Moreover, several radiolabeled CCK or gastrin analogs have been developed allowing to detect these tumors and their metastases in patients using in vivo cholecystokinin receptor scintigraphy, proving the feasibility of targeting CCK receptors in human tumors in vivo.

Keywords: tumor types, gastrointestinal cancers, small cell lung carcinoma, CCK Radioligands, CCK agonists

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [1239 - 1242]
Pages: 4
DOI: 10.2174/156802607780960546
Price: $65

Article Metrics

PDF: 9